06 Feb UK Classifies CBD as Medicine
UK classifies CBD as medicine –
The MHRA (Medicines and Healthcare products Regulatory Agency) recently announced that CBD (cannabidiol) will now be classified as a medicinal ingredient in healthcare products.
CBD is a compound found primarily in Industrial Hemp, which a growing body of research has proven effective in the treatment of a host of health ailments, some of which are quite severe and often difficult to treat with modern pharmaceutical medications. The classification of cannabidiol as a medicine means that the United Kingdom will now regulate the production, use, and quality standards of this ingredient in the country, which will also open the door for even more medical research about the benefits and effects of CBD on the human body. The reason for this decision is based, in part, on the massive amount of testimonial evidence from patients reporting that their symptoms are greatly reduced, or even cured, by CBD. According to an article from Sky News, Gerald Heddel, the director of inspection and enforcement at the MHRA, said:
“The change really came about with us offering an opinion that CBD is in fact a medicine, and that opinion was based on the fact that we noted that people were making some quite stark claims about serious diseases that could be treated with CBD.”
The implications of this new classification are, as of yet, unknown – it could potentially be a step in the right direction, though there may also be some negative consequences for current advocates and consumers of CBD in the UK. There’s concern that the result of these higher regulatory standards may actually undercut the availability of cannabidiol for people who are already dependant on the substance as a treatment. Some consumers believe that the new regulations are too strict and over-reaching, and that they may even lead to criminalization of patients using CBD products that don’t conform to these high quality standards.
Despite the potential risks to patients of cannabidiol, this decision is certainly in contrast with the United Kingdom’s and MHRA’s history regarding CBD – only a few months ago, they were sending “cease and desist” letters to producers of CBD in the country. Now, they officially consider it to have medicinal value, which does mark a turning point in the government’s opinion on the medical benefits of the compound, and that could eventually lead to a greater understanding of CBD in general, as well as establishing specific guidelines for the quality of these products.